Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Mengel

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Neurology|March 10, 2022
Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1Carlo Wilke, David Mengel, Ludger Schöls, et al.
Alzheimer'S Research & Therapy|March 21, 2020
Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increaseDavid Mengel, Wen Liu, Robert J Glynn, et al.
Brain Research|December 30, 2018
PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicityDavid Mengel, Wei Hong, Grant T Corbett, et al.
Disease Models & Mechanisms|September 4, 2023
Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3David Mengel, Isabel G Wellik, Kristen H Schuster, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse modelDavid Mengel, Isabel G Wellik, Kristen H Schuster, et al.
Pharmacoeconomics|March 19, 2021
Resource Utilization of Patients with Parkinson's Disease in the Late Stages of the Disease in Germany: Data from the CLaSP StudyChristopher Kruse, Sabrina Kretschmer, Anna Lipinski, et al.
Annals of Clinical and Translational Neurology|February 16, 2022
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4Christoph Kessler, Lina Maria Serna-Higuita, Carlo Wilke, et al.
International Journal of Molecular Sciences|March 3, 2018
Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular VesiclesFrancesc X Guix, Grant T Corbett, Diana J Cha, et al.
Brain : a Journal of Neurology|May 11, 2023
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment responseCarlo Wilke, David Pellerin, David Mengel, et al.
Nature|December 15, 2018
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormoneSilvia A Purro, Mark A Farrow, Jacqueline Linehan, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Neurology|March 10, 2022
Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1Carlo Wilke, David Mengel, Ludger Schöls, et al.
Alzheimer'S Research & Therapy|March 21, 2020
Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increaseDavid Mengel, Wen Liu, Robert J Glynn, et al.
Brain Research|December 30, 2018
PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicityDavid Mengel, Wei Hong, Grant T Corbett, et al.
Disease Models & Mechanisms|September 4, 2023
Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3David Mengel, Isabel G Wellik, Kristen H Schuster, et al.
Biorxiv : the Preprint Server for Biology|March 13, 2023
Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse modelDavid Mengel, Isabel G Wellik, Kristen H Schuster, et al.
Pharmacoeconomics|March 19, 2021
Resource Utilization of Patients with Parkinson's Disease in the Late Stages of the Disease in Germany: Data from the CLaSP StudyChristopher Kruse, Sabrina Kretschmer, Anna Lipinski, et al.
Annals of Clinical and Translational Neurology|February 16, 2022
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4Christoph Kessler, Lina Maria Serna-Higuita, Carlo Wilke, et al.
International Journal of Molecular Sciences|March 3, 2018
Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular VesiclesFrancesc X Guix, Grant T Corbett, Diana J Cha, et al.
Brain : a Journal of Neurology|May 11, 2023
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment responseCarlo Wilke, David Pellerin, David Mengel, et al.
Nature|December 15, 2018
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormoneSilvia A Purro, Mark A Farrow, Jacqueline Linehan, et al.
Pageof 6